• Theravance Biopharma 10% owner Eli Samaha sold 336,697 common shares in transactions dated June 29 to July 1, 2026.
• Sales were priced at $17.23, $17.13, $17.00 per share.
• Indirect beneficial ownership fell to 9,174,453 shares following the July 1 transaction.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Theravance Biopharma Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001877589-26-000001), on July 01, 2026, and is solely responsible for the information contained therein.